CROI 2024 Program Guide

Poster Sessions

ACTG 5381: Virologic and Resistance Outcomes After Switch to TLD for Failing 1st- or 2nd-Line ART Carole L Wallis, Caitlyn McCarthy , Catherine Godfrey, Sarita Shah, Cissy Kityo, Urvi M Parikh, Gary Maartens, Isaac Tsikhutsu, Fatma F Some, Samuel Pierre, Yvetot Joseph, Charles W Flexner, Michael D Hughes, John W Mellors, for the A5381 Team Viremia and Drug Resistance 2 Years After Routine Switching to Dolutegravir-Based First-Line ART Veronika Whitesell Skrivankova, Jacqueline Huwa, Guy Muula, Geldert D Chiwaya, Esau Banda, Shameem Buleya, Belinda Chihota, Joseph Chintedza, Carolyn Bolton, Thokozani Kalua, Roger Kouyos, Gilles Wandeler, Matthias Egger, Richard J. Lessells DTG Resistance in Patients with Previous ARV Experience and Viremia in Kenya Receiving DTG-Based ART Leonard Kingwara , Vera M Onwonga, Rukia S Madada, Peter Lokamar, John N Kiiru, James Wagude, Barbara Mambo, Caroline Mwangi, Rose Wafula, Kerri Penrose, Urvi M Parikh, Bhavna Chohan Emerging Dolutegravir Resistance in Lesotho Nadine Tschumi, Blaise Lukau, Lipontšo Motaboli, Katleho Tlali, Mpho Kao, Mathebe Kopo, Moleboheng Mokebe, Klaudia Naegele, Irene Ayakaka, Karoline Leuzinger, Jennifer A Brown, Niklaus D. Labhardt Resistance to Second-Generation InSTIs in Mexican PLWH: Emergence of the R263K Mutant Jannette A Juárez-González, Emiliano Ivan Sanchez Cruz, Luis A Angulo-Medina, Roberto A Rodriguez-Díaz, Elsa Y Vidal-Laurencio, Sofía Sierra Vásquez, Luis Enrique Soto Ramírez Virologic Outcomes With Tenofovir-Lamivudine-Dolutegravir for PI-Based Second-Line ART Failure Ying Zhao , Jacqueline Voget, Isaac Singini, Zaayid Omar, Vanessa Mudaly, Andrew Boulle, Gary Maartens, Graeme A Meintjes Poster Session-H1 | Dolutegravir Treatment and Resistance in Resource-Limited Settings 2:30 PM - 4:00 PM • Poster Hall C-D

675 LB

676

677

Poster Sessions • Wednesday

678

679

680

Poster Session-H4 | Archived Mutations and Sustained Suppression 2:30 PM - 4:00 PM • Poster Hall C-D

Impact of Archived Minority Populations With M184V/I on DTG/3TC for Maintenance of Viral Suppression Rosa De Miguel Buckley , Mayra Sigcha, Maria de Lagarde, Jose Luis Blanco, Rocio Montejano, Angela Gutiérrez Liarte, Esperanza Cañas Ruano, Arkaitz Imaz, Cristina Hernández, Antonio Ocampo Hermida, Pedro Gil, Rafael Delgado, Federico Pulido, Jose R Arribas, for the VOLVER-GESIDA 11820 Study Group

693

CROI 2024 159

New Investigator Scholarship

LB

NIS

Late-Breaking